Furthermore, the results of the present meta-analysis suggested that the BACH1 919Ser polymorphism may be correlated with a decreased risk of breast cancer in females with a family history of breast cancer and without BRCA1/2 mutations. This evidence concerns the gene BRCA1 and breast carcinoma.